Volume 29, Number 6—June 2023
Dispatch
Novel Avian Influenza Virus (H5N1) Clade 2.3.4.4b Reassortants in Migratory Birds, China
Table 1
Virus | HI titers of chicken antiserum against vaccine strains and H5N1/H5N8 isolates |
||
---|---|---|---|
Re-11, clade2.3.4.4h | Re-13, clade2.3.4.4h | Re-14, clade2.3.4.4b | |
Re-11, Dk/GZ/S4184/2017(H5N6) | 256 | 256–512 | 128 |
Re-13, Dk/FJ/S1424/2020(H5N6) | 32 | 256 | 2–4 |
Re-14, Ws/SX/4–1/2020(H5N8) | 8 | 16 | 256 |
Bs/EC/74-Lg/2021(H5N1) | 16 | 8 | 128 |
Ws/NC/AK2-O/2021(H5N1) | 2–4 | 2–4 | 32 |
Ws/HN/1-K/2020(H5N8) | 8 | 8 | 64 |
Ws/HN/1-G/2020(H5N8) | 8 | 8 | 64 |
*H5 Re-11 vaccine was used in poultry in mainland China during December 2018–December 2021. H5 Re-13 and Re-14 vaccines have been deployed since January 2022. HI, hemagglutination inhibition.
1These authors contributed equally to this article.
Page created: April 17, 2023
Page updated: May 17, 2023
Page reviewed: May 17, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.